Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score
- 15 July 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 108 (2) , 161-165
- https://doi.org/10.1161/01.cir.0000080289.72166.cf
Abstract
Background— Although C-reactive protein (CRP) predicts vascular risk, few data are available evaluating the relation between CRP and the Framingham Coronary Heart Disease Risk Score (FCRS). Methods and Results— CRP levels were compared with calculated 10-year FCRS in a cross-sectional survey of 1666 individuals free of cardiovascular disease. Among men and women not using hormone replacement therapy (HRT), CRP levels were significantly related to 10-year Framingham Coronary Heart Disease Risk categories [total cholesterol (TC) score for men and women: r=0.29 and r=0.22, respectively; LDL cholesterol score for men and women: r=0.29 and r=0.22, respectively, all probability values <0.01]. However, CRP levels correlated minimally with individual components of the FCRS, which included age (rmen=0.17, rwomen=−0.003), TC (rmen=−0.02, rwomen=−0.006), HDL-C (rmen=0.13), LDL-C (rmen=−0.0002, rwomen=0.012), blood pressure (rmen=0.18, rwomen=0.22), diabetes (rmen=0.10, rwomen=0.07), and smoking (rmen=0.16, rwomen=0....Keywords
This publication has 15 references indexed in Scilit:
- Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular EventsNew England Journal of Medicine, 2002
- Should statin therapy be considered for patients with elevated C-reactive protein? The need for a definitive clinical trial.Published by Oxford University Press (OUP) ,2001
- Validation of the Framingham Coronary Heart Disease Prediction ScoresJAMA, 2001
- Effect of Statin Therapy on C-Reactive Protein LevelsJAMA, 2001
- The Pravastatin Inflammation CRP Evaluation (PRINCE): Rationale and designAmerican Heart Journal, 2001
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Cardiovascular disease risk profilesAmerican Heart Journal, 1991